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ABSTRACT
Biliary tract disease is a relatively uncommon, heterogenous disease in pregnancy. Specifical-
ly, acute eholecystitis can be especially difficult to recognize in pregnancy. However, once diag-
nosed, the initial management plan should be conservative and include antibiotic therapy. Subse-
quent management depends on the gestational age at diagnosis. Surgical therapy, when indicated,
should not be delayed and a planned intervention during the second trimester appears to offer a
better outcome than surgery performed under emergent conditions. Infect. Dis. Obstet. Gyneeol.
4:303-309, 1996. (C) 1997 wiey-I.iss, Inc.
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holelithiasis is a condition which effects ap-
proximately 20 million American women with
million new cases diagnosed each year. Women
of reproductive age are 4 times more likely than
men of similar age to develop gallbladder disease,z
Epidemiologic studies indicate that the incidence
of cholesterol gallstones rises abruptly as women
enter the childbearing years.
3 In fact, several stud-
ies show a direct relationship between parity and
risk of developing biliary stones.4-6 Generally
though, biliary tract disease is a relatively uncom-
mon occurrence during pregnancy. A recent review
of more than 45,000 pregnant women revealed the
incidence of symptomatic biliary tract disease to be
0.16% in pregnancy. 7 Despite its relatively uncom-
mon occurrence during pregnancy, 81% of women
with symptoms of gallbladder disease had their first
attack within 1 year of pregnancy. Pregnancy then
seems to predispose women to developing biliary
tract disease.
Biliary tract disease encompasses a continuum
of pathologic entities which includes biliary sludg-
ing, cholelithiasis, cholecystitis, choledocholithia-
sis, and cholangitis. Biliary sludge or the supersatu-
ration of bile with cholesterol, is an important pre-
cursor to gallstone formation. The exact prevalence
of cholelithiasis in pregnancy is essentially un-
known since 50% of women with gallstones are
asymptomatic. Efforts to identify asymptomatic
cholelithiasis in pregnancy using ultrasound have
produced variable results; however, the best esti-
mate of incidence appears to be between 2.5% and
4.5%.8-1o
In addition to pregnancy, several other factors
are strongly associated with gallbladder disease.
Ethnicity contributes to the risk for developing bil-
iary disease. In particular, 70% of Native American
women older than 30 years of age develop choleli-
thiasis. Mexican American women have an inter-
mediate prevalence of about 14% with Caucasians
and Black women at 4% and 5%, respectively.1
Chilean women are also reported to be at high risk
for developing gallstones.e In addition, heredity
has been implicated as a contributing factor; 20% of
first degree relatives with cholelithiasis will de-
velop symptomatic gallstones.1 Finally, age and
obesity are also commonly associated with biliary
disease.
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As stated earlier, biliary disease, including acute
cholccystitis, occurs infrequently during the preg-
nant state. In fact, the prevalence of acute chole-
cystitis in pregnancy ranges from 1/1,000 to
1/10,000 births. 13,14 Cholclithiasis is obviously the
major etiologic factor in the development of acute
cholecystitis and it has been established that the
pregnant state predisposes women to gallstone for-
mation. In light of the key role they play in the
etiology of acute cholecystitis, it is only appropriate
that a brief description of the pathogenesis of gall-
stones be provided in this review.
PATHOGENESIS OF BILIARY STONES
Gallstones are composed of cholesterol, bilirubin,
calcium salts, and protein. Each of these ingredi-
ents occurs in various percentages. Specifically,
there are cholesterol and non-cholesterol stones.
Non-cholesterol stones are frequently associated
with a chronic hemolytic condition and contain a
higher bilirubin concentration. Brown pigment
non-cholesterol stones are often associated with in-
fection since bacteria are likely to hydrolyze con-
jugated bilirubin into calcium salts. This hydrolysis
accounts for the brown coloration of many non-
cholesterol gallstones.
Cholesterol gallstones, 75% of all stones in the
Western world, form when cholesterol concentra-
tions exceed the ability of bile acids to maintain
cholesterol in solution. At higher cholesterol con-
centrations, cholesterol micelles coalesce precipi-
tating crystals. This coalescence yields gallbladder
sludge, which is merely thickened mucoprotein
with entrapped cholesterol crystals. Sludge is an
important precursor to gallstone formation as the
crystals bind to the biliary proteins and ultimately
result in cholelithiasis, is
The increased risk of developing gallstones dur-
ing pregnancy is due to several factors. First, the
gallbladder volume is increased during the second
and third trimesters. Second, gallbladder motility is
decreased in pregnancy, possibly due to elevated
progesterone levels. The evidence, however, is
only circumstantial as progesterone has been
proved only to inhibit gastrointestinal smooth
muscle contractility in vitro.6
The theorized decrease in motility alone cannot
completely account for the increased bile volume
noted in pregnancy. Analysis of sequential films for
gallbladder volume revealed a significant increase
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in residual volume after gallbladder emptying. 17
There is also a 50% increase in the bile acid pool
associated with a concomitant steroid-induced in-
crease in cholesterol secretion during pregnancy.
Together with the replacement of deoxycholic and
chenodeoxycholic bile acids with cholcic acid, in-
creased volume and decreased motility of the gall-
bladder enhance the development of biliary stones.
When these pregnancy-induced changes occur
with a metabolic and/or hereditary predisposition
to developing gallstones, the likelihood of biliary
disease is predictably high.
MICROBIOLOGY OF BILIARY DISEASE
Identifiable gallstones do not have to be present in
order to develop symptomatology. In fact, biliary
sludge can precipitate biliary pain, acute cholecys-
titis, or even pancreatitis. When sludge develops
into gallstones and they obstruct the cystic or com-
mon bile ducts, bacterial invasion can occur. How-
ever, the primary cause of acute cholecystitis is not
bacterial invasion. Instead, it is frequently a chemi-
cal inflammation. After obstruction, inflammation,
hyperemia, and edema of the gallbladder follow.
Subsequent venous and lymphatic obstruction
yields ischemia. It is only after this secondary isch-
emia that bacterial invasion and infection com-
monly occur.8
The presence of organisms in the bile, per se,
does not necessarily imply an active infection.
Bactibilia has only been reported in up to 65% of
women with acute cholecystitis. In fact, most re-
ports state that only 50% of patients with acute
cholecystitis will have positive bile cultures.9 Con-
verscly, bactibilia is found in 20-30% of patients
with biliary concrements that have minimal or no
signs of obstruction. Therefore, the mere presence
of biliary calculi seems to support some bacterial
growth. 18,9 Ultimately, then, acute cholecystitis
can be thought of as a heterogeneous disease.
The incidence of bactibilia varies significantly
with the stage of disease and the patient’s age.
Also, as expected, with infections originating in the
gut, the array of organisms in acute cholecystitis is
broad. It includes both aerobes and anaerobes with
a predominance of enteric gram-negative organ-
isms (Table 1). Escherichia coli is the most common
organism found in all studies of men and women
diagnosed with acute cholecystitis. Klebsiella, Pro-
teus, Enterococci, and Streptococci together with
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TABLE I. Common causes of cholecystitis8
Aerobic
Escherichia coli
Klebsiella sp.
Enterococci
Proteus sp.
Anaerobic
Bacteroides sp.
Clostridium sp.
Anaerobic cocci
E. coli account for 75% of all bacterial strains re-
covered during acute cholecystitis.
18 There has
been a slow increase in anaerobic isolates which is
most likely due to improved culturing techniques.
Nevertheless, of the anaerobes recovered, Bacte-
roides and Clostridia are among the most com-
18 mon.
Although the bacteria of acute cholecystitis are
undoubtedly enteric in origin, the route of entry
into the biliary tract remains uncertain. Ascending
infection would seem to be the most likely expla-
nation. However, there is good evidence that he-
matogenous spread with direct infection through
the thickened gallbladder walls also leads to acute
cholecystitis.
18
DIAGNOSIS
To effectively treat acute cholecystins you must
first recognize the clinical picture. Other than bil-
iary disease, the differential diagnosis in a pregnant
woman with right upper quadrant pain includes
prccclampsia, pyclonephritis, appendicitis, and
even gastric ulcer. After initial evaluation excludes
these and other less common entities from the dif-
ferential diagnosis, the diagnosis of biliary disease
should be further investigated. As stated earlier,
differentiating cholelithiasis from acute cholecysti-
tis can be difficult. This is especially true when
pregnancy complicates the clinical picture. Some
clinicians argue that differentiating between the
two would not affect management. At any rate, the
clinical manifestations of acute cholecystitis during
pregnancy are essentially the same as the non-
pregnant state.
HISTORY
An episode of biliary pain usually begins with right
upper quadrant or mid-epigastric pain which may
increase in severity. Biliary colic begins quite sud-
denly and may radiate to the interscapular area, to
the angle of the right scapula, or to the right shoul-
der. It may be precipitated by a fatty meal or by
consumption of a large meal following a period of
fasting. Typically though, biliary colic occurs in a
diurnal pattern with pain peaking around midnight.
Nausea and vomiting also frequently accompany
episodes of colic. Finally, 70-80% of patients will
have a history of colic attacks and fatty food intol-
erance. 13 Increasing severity of colicky pain, fever,
or chills (rigors) usually implies an underlying com-
plication, i.e., cholecystitis, pancreatitis, or cholan-
gitis.
PHYSICAL EXAMINATION
Physical examination reveals right upper quadrant
tenderness. This is usually associated with an in-
crease in pain to palpation upon deep inspiration
(Murphy’s sign). Fever and tachycardia may indi-
cate an underlying infection. The presence of peri-
toneal signs, guarding, rigidity, and rebound, are
extremely ominous signs and may reflect rupture of
the gallbladder.
LABORATORY FINDINGS
Laboratory evaluation may provide assistance in di-
agnosis but it is clear that the clinical course will
dictate the management plan. Laboratory studies
commonly performed when evaluating these
women include blood leukocyte count, evaluation
of hepatic function, serum bilirubin, amylase, li-
pase, and alkaline phosphatase. There are numer-
ous alterations in several of these laboratory param-
eters which normally occur in pregnancy and can
limit their usefulness. The blood leukocyte count
varies considerably during normal pregnancy. Val-
ues can range from 5,000 to 12,000/ml and these
values may rise significantly with exercise or labor.
Also, alkaline phosphatase activity nearly doubles
during normal pregnancy. Finally, postprandial
plasma levels of total bile acids progressively in-
crease during pregnancy. Therefore, laboratory
evaluation will only provide clues in the diagnosis
of biliary tract disease during pregnancy. For ex-
ample, serum bilirubin may be mildly elevated and
leukocytosis may be present. If bilirubin remains
elevated with persistent jaundice, common duct
stones should be suspected. If there is significant
leukocytosis in addition, an underlying infectious
process should be considered. Finally, serum amy-
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lase, lipase, and alkaline phosphatase may be of
some assistance in identifying pancreatic involve-
ment. 17
RADIOGRAPHIC EVALUATION
Ultrasound has revolutionized the accuracy and
safety of diagnosing biliary tract disease. It has all
but replaced oral cholecystography and intravenous
cholangiography as the standard for diagnosis of
gallbladder disease. Ultrasonography, as a rule
though, provides no direct evidence of acute cho-
lecystitis. Conversely, intravenous cholecystogra-
phy gives a more functional diagnostic view of cho-
lecystitis by directly revealing blockage of the cys-
tic duct and biliary stasis.
Additional sonographic findings may aid in dif-
ferentiating cholelithiasis from acute eholecystitis.
These include gallbladder wall thickening, gall-
bladder distention, and tenderness upon deforma-
tion of the gallbladder with the ultrasound trans-
ducer (sonographic Murphy’s sign). However, none
of these findings is an absolute indicator of acute
cholecystitis. In fact, when reviewing the literature,
several studies both support and refute the use of
gallbladder wall thickening and sonographic Mur-
phy’s sign to differentiate biliary colic from acute
calculous or acalculos cholecystitis,s’lg,z
In other words, ultrasound is imperfect in dem-
onstrating biliary stones impacted in the cystic duct
and this, unfortunately, is the cardinal sign of acute
cholecystitis,e Nevertheless, ultrasound has no
known medical contraindications or adverse side
effects and should be used as the first line of diag-
nostic study. One study reported a 96% sensitivity
and 88% specificity for ultrasound in the diagnosis
of cholecystitis when combined with all of the
clinical criteria previously described,e The overall
accuracy of ultrasound in diagnosing acute chole-
cystitis is 93%. The same study cited above re-
ported an overall accuracy of intravenous cholecys-
tography as 88%; however, this was felt to be due to
impaired hepatic excretion of contrast medium.
Finally, the use of intravenous contrast media
always runs the risk of hypersensitivity reactions. It
is, therefore, reasonable to conclude that ultra-
sound is accurate, safe, and the most practical
method for diagnosing acute cholecystitis in preg-
nancy.
TREATMENT
Medical Management
The primary issue in the management of acute
cholecystitis is when to intervene surgically. Initial
medical therapy is appropriate in all patients with
biliary tract disease, however, clinicians should not
procrastinate when surgery is indicated. Medical
therapy includes eliminating oral intake, nasogas-
tric suction, correction of electrolyte abnormalities,
and analgesia. Morphine analgesia and its deriva-
tives should be avoided, as they may cause spasm
of the sphincter of Oddi. This spasm may exacer-
bate an already painful condition. Finally, intrave-
nous antibiotic therapy is usually indicated in pa-
tients with suspected acute cholccystitis, even
though superinfection of the bile/gallbladder may
not occur until the latter stages of disease.
The combination of a penicillin and an
aminoglycoside has long been recommended as the
initial treatment of choice for patients with infec-
tions of the biliary tract. This initial antibiotic
therapy is empirically based on the bacterial flora
likely to bc encountered in the biliary tract.
Aminoglycosides are used to treat gram-negative
facultativc biliary pathogens including pseudomo-
nas. Penicillins offer adequate gram-positive cov-
erage. Specifically, ampicillin will cover most an-
aerobes and enterococcus species. Therefore, their
combination would empirically provide good anti-
biotic coverage in patients with evidence of acute
cholecystitis.
Concern about aminoglycosidc-induced nephro-
toxicity in patients with jaundice and sepsis
coupled with the development of newer, more ef-
fective cephalosporins has challenged penicillin
plus aminoglycoside use as the preferred treatment
in acute cholccystitis. Specifically, improved cov-
erage against Bacteroides sp. by some second and
third generation cephalosporins has led to their in-
creased use in both prophylaxis and treatment re-
gimes. In one study, cefepime, a third generation
cephalosporin, was compared to mezlocillin and
gentamicin therapy in patients with acute chole-
cystitis undergoing cholecystectomy. The results
indicated that single drug therapy with cefepimc
was as effective as combination therapy with mcz-
locillin and gentamicin, el Cefepime, like many
later generation cephalosporins, requires 12 h dos-
ing and can achieve high bile, blood, and gallblad-
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der levels. Ultimately, with increased cost con-
sciousncss, decreased drug monitoring and fewer
doses mean lower overall costs related to cephalo-
sporin use.
Pipcracillin, an extended spectrum penicillin,
has broad coverage against all organisms commonly
bound in the biliary tract, excellent biliary excre-
tion, and negligible nephrotoxicity. It has also been
shown to be efficacious in patients with acute cho-
lecystitis, zz,z’ The overall cure rate for acute cho-
lecystitis in patients treated with piperacillin, am-
picillin and tobramycin, or cefopcrazonc was 92%
with no difference in any of the three groups,zz
Hence, when considering antibiotic therapy in pa-
tients with acute cholecystitis, the standard of a
penicillin and an aminoglycosidc remains an effec-
tive regimen. However, when considering more
current issues such as cost containment, alterna-
tives including extended spectrum penicillins or
third generation cephalosporins cannot be ignored.
In managing acute cholecystitis in pregnancy,
many physicians advocate initial non-operative
management in an effort to prevent surgical inter-
vention prior to completion of the pregnancy. The
pregnancy outcomes are highly dependent on the
trimester during which the biliary symptoms occur.
One study evaluated 26 pregnant patients with
acute cholecystitis in all three trimesters. Only 2 of
the 7 patients who presented in the first trimester
had pregnancies which went to term, whereas all
patients who presented in the third trimester com-
pleted a successful pregnancy,z4 Twenty of the pa-
tients did not require operation before resolution of
the pregnancy. Non-operative therapy has classi-
cally been the primary goal for pregnant women
with acute cholecystitis.
Having said that, there is evidence to suggest a
high rate of recurrence of biliary pain in pregnancy
complicated by cholelithiasis and cholecystitis. In a
recent retrospective review of 44 women with bil-
iary colic or cholecystitis, experience with conser-
vative, non-operative therapy was not favorable.
Twenty-six of the 44 patients were managed con-
servatively and 58% of those had recurrent symp-
toms. Twenty-seven percent of these women were
rehospitalized two or more times during their preg-
nancy. The average hospital stay for these women
was 14 days as opposed to 6 days for the group with
surgical intervention,zs
Surgical Management
The implication is that cholecystcctomy should bc
considered early in the management of these
women. With regard to non-obstetric surgical
therapy, several comments can be made. During
pregnancy appendicitis is the most common indi-
cation for non-obstetric surgery followed by adnex-
al masses and cholecystectomy,z6 Cholecystectomy
is performed at a rate of 1-6/10,000 pregnancies,z7
In a review of approximately 50,000 pregnancies,
the preterm delivery rate within 2 weeks of any
surgery was significantly higher in the third trimes-
ter than in the second trimester (25.7% vs. 8.2%).
Also, there was a trend toward prcterm delivery for
those procedures performed emergently vs. those
that were planned. Finally, in this study, tocolytic
agents were not found to be beneficial,z7
Based on the current literature, the following
overall recommendations can be made with regard
to management of pregnant women with acute cho-
lecystitis. First, prepregnancy cholecystectomy is
advised in those women with a history of choleli-
thiasis. Second, biliary colic or acute cholccystitis
occurring during the first trimester of pregnancy
should initially be treated medically. If possible,
elective surgery should be scheduled for the sec-
ond trimester. Biliary symptoms occurring in the
second trimester should ideally be treated surgi-
cally. Finally, symptoms of biliary colic or evidence
of acute cholecystitis in the third trimester should
be treated medically, when possible. Postpartum
surgical therapy should then be pursued,zs In con-
clusion, due to high recurrence rates of biliary
symptoms in pregnant women with acute cholecys-
titis, surgery should be considered early in manage-
ment as opposed to postponing definitive therapy.
Once the decision for surgical intervention has
bccn made, the question is which approach should
be used. The options include endoscopic retro-
grade cholangiopancreatography (ERCP) with
sphincterotomy and stone removal, laparoscopic
cholecystectomy, or open cholecystectomy. Prior to
any of the above procedures, however, appropriate
antibiotics should be instituted.
With respect to ERCP with sphinctcrotomy and
stone removal, conventional wisdom is that due to
potential radiation-induced damage to the fetus,
fluoroscopic procedures should be avoided. Several
studies in the second and third trimesters, how-
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ever, have reported successful pregnancy outcomes
following ERCP with biliary stone removal,zS,z9
Additionally, Hoffman and Cunningham3 re-
ported four pregnant women who underwent
ERCP during the first trimester. In this report, ra-
diation exposure after appropriate abdominal
shielding was calculated and found to be well be-
low levels at which damage to the fetus can occur."
Ultimately, then, ERCP with sphincterotomy and
stone removal and possible stcnting of the gallblad-
der appears to be a safe procedure in pregnant
women with uncomplicated cholelithiasis.31
In cases of acute cholecystitis or complicated
cholelithiasis, depending on gestational age at di-
agnosis, the surgical management may differ. Lap-
aroscopic cholecystectomy in pregnancy was first
reported in 1991. 3z The laparoscopic approach
theoretically avoids potential postoperative compli-
cations such as thrombophlebotic and embolic
events in the pregnant, hypcrcoagulablc state. This
report described a pregnancy in the early second
trimester with the uterus at the pelvic brim. The
patient was discharged on postoperative day with
an eventual successful pregnancy outcome)z Lap-
aroscopic cholecystectomy has been performed
successfully in non-pregnant patients with acute
cholecystitis, common duct stones, previous surgi-
cal history, obesity, coagulopathy, and dilated
bowel.33 Also, gynecologic laparoscopics are fre-
quently performed during pregnancy.e Therefore,
a laparoscopic cholecystectomy is a reasonable con-
sideration in pregnant women. Despite longer sur-
gery times, reduced morbidity and mortality along
with decreased cost of hospitalization justifies its
use in experienced hands. Pregnancy should not be
considered an absolute contraindication to the lap-
aroscopic approach in these patients.
There is no consensus, however, at what gesta-
tional age/uterine size laparoscopy would be con-
traindicated. Clear contraindications such as sepsis,
cholangitis, common duct stones, and portal hyper-
tension would still apply."’,4 If it is the opinion of
the experienced surgeon that he or she cannot
safely place the trocar into the peritoneal cavity or
perform an open laparoscopy, the traditional lapa-
rotomy approach should be the treatment of
choice. As stated previously, tocolytic therapy has
been shown to be of no benefit in these patients,z6
CONCLUSION
Biliary tract disease in pregnancy is a relatively un-
common occurrence. Because of the heterogeneous
nature of the disease, progression to acute chole-
cystitis can be difficult to recognize. Once diag-
nosed, the initial management plan should be con-
servative and include institution of antibiotic
therapy. Then, depending on the gestational age at
diagnosis, the management plan may differ. Surgi-
cal intervention, when indicated, should not be de-
layed and a planned intervention during the second
trimester appears to offer a better outcome than
surgery performed under emergent conditions,e6
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